Robotic Biopsy Devices Market Analysis, Segmentation, Key Players, Opportunities And Forecast 2032

 The global Robotic Biopsy Devices Market was valued at US$ 386.4 million in 2021 and is expected to grow at a CAGR of 9.4% during the forecast period (2022-2032). Robotic biopsy systems are the global market leader, with a market share of approximately 59.8% in 2021. By the end of 2032, the global robotic biopsy devices market is expected to be worth approximately US$ 1.1 billion.

One of the most significant cutting-edge technologies in neurosurgery is robot-assisted biopsy for brain tumors. A robot-assisted biopsy is used to increase the safety and effectiveness of biopsy technique, which is highly desired when organizing the management of tumor pathology.

Get a PDF Sample with the Latest Market Insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15412

The main objective of this cutting-edge technology is to add safety equipment to the modern neurosurgery operative inventory so that it can methodically improve the precision and accuracy in operation theaters, which is not otherwise conceivable. Additionally, robotic biopsy makes the thorough preoperative process easier than other types.

The market for robotic biopsy devices is anticipated to grow at a fast pace over the projected years due to rising need for safe and effective minimally invasive procedures and the growing use of automated systems in the healthcare sector. It can be further attributed to rapid transformation of conventional healthcare systems to integrated digital technology.

Key Takeaways: Robotic Biopsy Devices Market

  • By product, the systems segment is expected to showcase high growth at a CAGR of 4% by the end of 2032.
  • By application, the brain biopsy category is leading the global robotic biopsy devices market and is projected to exhibit a CAGR of 3% during the forecast period.
  • By end user, hospitals held around 5% of the global robotic biopsy devices market share in 2021.
  • The U.S. currently dominates the North America robotic biopsy devices market and it had generated a share of about 8% in 2021.
  • The U.K. is set to hold a share of nearly 2% in the global robotic biopsy devices market during the assessment period.

"Increasing use of automated technologies for surgical procedures and growing global burden of chronic diseases are expected to drive sales of robotic biopsy devices," says an analyst of Future Market Insights.

Gain complete access to the report @ https://www.futuremarketinsights.com/reports/robotic-biopsy-devices-market

Competition Landscape: Robotic Biopsy Devices Market

The market for robotic biopsy devices is oligopolistic, with the presence of a few established manufacturers. Product range of every player in the market varies as per the competitors' licensed novel devices with unique applications. Key players are striving to gain regulatory authorizations for creating new medical devices, generating high product sales, and initiating marketing purposes.

  • In October 2021, Medtronic reported that the Hugo robotic-assisted surgery (RAS) system had been granted the CE (Conformité Européenne) Mark, allowing for sales of the system across Europe.

Key Companies Profiled:

  • Medtronic
  • Renishaw plc
  • iSYS Medizintechnik GmbH
  • Mazor Robotics
  • Biobot Surgical Pte Ltd
  • Medrobotics
  • Medtech SA

Robotic Biopsy Devices Market Outlook by Category

By Product:

  • Systems
  • Instrument & Accessories

By Application:

  • Brain Biopsy
  • Lung Biopsy
  • Prostate biopsy
  • Other

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Academic & Research Institutes

Comments

Post a Comment

Popular posts from this blog

Orthopedic Trauma Devices Market is projected to reach a valuation of US$ 21.2 Bn by 2033 | FMI

Image
  The net worth of the Orthopaedic Trauma Devices Market is expected to increase from US$ 10.7 billion in 2023 to more than US$ 21.2 billion by 2033. From 2023 to 2033, the orthopaedic trauma device market is expected to grow at a 7.1% CAGR . To learn more about this report @ https://www.futuremarketinsights.com/reports/orthopedic-trauma-devices-market With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis on Orthopedic Trauma Devices market. FMI offers insights into the market data on over 5000+ drugs for more than 100 countries, which further aids the research on current and upcoming market scenario for the Orthopedic Trauma Devices market. Our expert researchers and analysts for healthcare tracks the data of established players as well as new entrants in medical industry to provide an unbiased analysis for a sound and financial decision. Over the past decade, healthcar
Read more

Insulin Pen Market is forecasted to surpass US$ 46.9 Bn by 2031

Image
Diabetes is becoming more common as poor lifestyle choices continue to be prominent around the world. Insulin pens are a widely used method of treating diabetic individuals. Given this, Future Market Insights predicts that insulin pen sales will reach US$ 30,407 million in 2021. Insulin pens are used by diabetes patients to avoid problems including cardiovascular diseases that may arise from this lifestyle-based ailment. To overcome problems related to conventional methods of insulin administration, insulin pens make the process easier and faster. Get More Information on this Report @ https://www.futuremarketinsights.com/reports/insulin-pens-market According to the WHO, approximately 1.2 million deaths were caused due to diabetes in 2019 globally. To reduce the number of deaths or sufferings due to diabetes, the development of innovative techniques and products for the treatment and maintenance of diabetes is essential. Type 2 diabetes cases are common, but it can be prevented or de
Read more

Molecular Biology Enzymes, Kits & Reagents Market Size, Share, Growth, Forecast through 2032

Image
  According to a recent Future Market Insights report, the global Molecular Biology Enzymes, Kits & Reagents Market will grow dramatically between 2022 and 2032. By 2032, global sales of molecular biology enzymes, kits, and reagents are expected to total approximately US$ 48,476.41 million. Technological Advancements Leading to Enhanced Efficiency & Greater Precision of Molecular Biology Enzymes, Kits & Reagents The manufacturers of molecular biology enzymes, kits, and reagents have contributed significantly to technical breakthroughs by focusing on creating cutting-edge goods in an effort to diversify their product offerings. The cutting-edge items support the study procedures by providing features like increased precision and efficiency. One of the best instances of this is Thermo Fisher Scientific, Inc.’s SMART Digest Kit, which was created specifically for biopharmaceutical and proteomic applications. This kit reduces the time required for sample preparation while
Read more